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BACKGROUND  
Future human space travel will consist primarily of long-duration missions onboard the International Space Station 
(ISS) or exploration-class missions to Mars, its moons, or nearby asteroids. Astronauts participating in long-duration 
missions may be at an increased risk of oxidative stress and inflammatory damage due to radiation, psychological 
stress, altered physical activity, nutritional insufficiency, and hyperoxia during extravehicular activity. By studying 
one identical twin during his 1-year ISS mission and one ground-based twin, this work extends a current NASA-
funded investigation to determine whether these spaceflight factors contribute to an accelerated progression of 
atherosclerosis. This study of twins affords a unique opportunity to examine the spaceflight-related atherosclerosis 
risk independent of the confounding factors associated with different genotypes. 
 
PURPOSE 
The purpose of this investigation is to determine whether biomarkers of oxidative and inflammatory stress are 
elevated during and after long-duration spaceflight and determine if a relation exists between levels of these 
biomarkers and structural and functional indices of atherosclerotic risk measured in the carotid and brachial arteries. 
These physiological and biochemical data will be extended by using an exploratory approach to investigate the 
relationship between intermediate phenotypes and risk factors for atherosclerosis and the metabolomic signature 
from plasma and urine samples. Since metabolites are often the indirect products of gene expression, we will 
simultaneously assess gene expression and DNA methylation in leukocytes. 
 
HYPOTHESIS 
We predict that the space-flown twin will experience elevated biomarkers of oxidative stress and inflammatory 
damage, altered arterial structure and function, accelerated telomere shortening, dysregulation of genes associated 
with oxidative stress and inflammation, and a metabolic profile shift that is associated with elevated atherosclerosis 
risk factors. Conversely, these will not be observed in the ground-based twin. 
 
METHODS 
We will measure blood and urine biomarkers of oxidative stress and inflammation as well as arterial structure and 
function (carotid intima-medial thickness and brachial artery flow-mediated dilation) in one twin astronaut before, 
during, and after long-duration spaceflight and in his twin serving as a ground-based control. Furthermore, we will 
measure metabolomics (targeted and untargeted approaches) and genomic markers (DNA methylation, mRNA gene 
expression, telomere length) to elucidate the molecular mechanisms involved. A panel of biomarkers of oxidative 
and inflammatory stress will be measured in venous blood samples and 24-h (in-flight) and 48-h (pre- and post-
flight) urine pools twice before flight, early (flight days 15 and 60) and late (2 weeks before landing) during the 
mission, and early in the post-flight recovery phase (~3-5 days after landing). Arterial structure, assessed from 
measures of intima-media thickness, will be measured at the same times. Arterial function will be assessed using 
brachial flow-mediated dilation, a well-validated measure used to assess endothelium-dependent vasodilation and a 
sensitive predictor of atherosclerotic risk, only before and after spaceflight.  
 
DISCUSSION 
Pre- and in-flight data collection is in progress for the space-flown twin, and similar data have been obtained from 
the ground-based twin. Blood and urine samples will be batch processed when received from ISS after the 
conclusion of the 1-year mission. Results from these individual subjects will be compared to the larger complement 
of subjects participating in the companion study currently ongoing in ISS astronauts.  
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